Filtered By:
Drug: Yervoy
Vaccination: Cancer Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 36 results found since Jan 2013.
Immunotherapy for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives
J Clin Med. 2023 Feb 11;12(4):1446. doi: 10.3390/jcm12041446.ABSTRACTProstate cancer is the most commonly diagnosed cancer in men worldwide, making up 21% of all cancer cases. With 345,000 deaths per year owing to the disease, there is an urgent need to optimize prostate cancer care. This systematic review collated and synthesized findings of completed Phase III clinical trials administering immunotherapy; a current clinical trial index (2022) of all ongoing Phase I-III clinical trial records was also formulated. A total of four Phase III clinical trials with 3588 participants were included administering DCVAC, ipilimumab,...
Source: Clinical Prostate Cancer - February 25, 2023 Category: Cancer & Oncology Authors: Laeeq Ur Rehman Muhammad Hassan Nisar Wajeeha Fatima Azza Sarfraz Nishwa Azeem Zouina Sarfraz Karla Robles-Velasco Ivan Cherrez-Ojeda Source Type: research
Cancer immunotherapy: an evolving paradigm
J Zhejiang Univ Sci B. 2022 Oct 15;23(10):791-792. doi: 10.1631/jzus.B2210001.ABSTRACTThe inhibition of the host's natural immune response by tumor cells was widely reported in the early phases of the development of oncology therapy, and the concept of employing the host's immune system to treat cancer, i.e. tumor immunotherapy, is not new. However, as a result of early theoretical constraints, clinical application of immunotherapy did not go smoothly and lagged significantly behind radiation and chemotherapy. The path has been winding, but the future now seems promising. Immunotherapy research has advanced enormously as a...
Source: J Zhejiang Univ Sci ... - October 13, 2022 Category: Science Authors: Aifu Lin Source Type: research
